CAPR ▲ +2.2% - Capricor Therapeutics, Inc.
$CAPR u/g Overweight @ Piper pt 25
Capricor Therapeutics rose 2.2% following an upgrade to Overweight by Piper Sandler, which set a price target of $25 on the stock. The upgrade and target price provided a near-term catalyst for the modest gains.
01-SEP-2026 05:16 AM ET
Share this post
More filings for $CAPR
CAPR - Capricor Therapeutics, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026CAPR - Capricor Therapeutics, Inc. - SEC Filing Update (13-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 13, 2026CAPR ▲ +0.8% - Capricor Therapeutics, Inc.Nov 6, 2026CAPR - Capricor Therapeutics, Inc. - SEC Filing Update (14-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 14, 2026CAPR - Capricor Therapeutics, Inc. - SEC Filing Update (14-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 14, 2026CAPR - Capricor Therapeutics, Inc. - SEC Filing Update (19-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 19, 2026
View full $CAPR filing history →💬 Comments
Loading comments…
Leave a comment
